Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
8.06
+0.43 (5.64%)
Nov 11, 2026, 4:00 PM EST - Market closed
Eupraxia Pharmaceuticals Employees
Eupraxia Pharmaceuticals had 49 employees as of December 31, 2025. The number of employees increased by 16 or 48.48% compared to the previous year.
Employees
49
Change (1Y)
16
Growth (1Y)
48.48%
Revenue / Employee
n/a
Profits / Employee
-$1,257,637
Market Cap
529.88M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 49 | 16 | 48.48% | 49 | 0 |
| Dec 31, 2024 | 33 | 4 | 13.79% | 33 | 0 |
| Dec 31, 2023 | 29 | 8 | 38.10% | 29 | 0 |
| Dec 31, 2022 | 21 | 0 | - | 21 | 0 |
| Dec 31, 2021 | 21 | 9 | 75.00% | 19 | 2 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| REGENXBIO | 371 |
| Capricor Therapeutics | 231 |
| Neurogene | 131 |
| Oculis Holding AG | 60 |
| Shattuck Labs | 40 |
| DiaMedica Therapeutics | 35 |
| Ovid Therapeutics | 23 |
EPRX News
- 19 hours ago - Eupraxia Pharmaceuticals price target raised to $16 from $11 at H.C. Wainwright - TheFly
- 1 day ago - Eupraxia Pharmaceuticals Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 1 day ago - Eupraxia Pharmaceuticals Establishes At-The-Market Offering Program - GlobeNewsWire
- 1 day ago - Eupraxia Pharmaceuticals Reports Third Quarter 2026 Financial Results - GlobeNewsWire
- 1 day ago - Eupraxia Pharmaceuticals Earnings release: Q3 2026 - Filings
- 1 day ago - Eupraxia Pharmaceuticals Report: Q3 2026 - Filings
- 1 day ago - Eupraxia Pharmaceuticals MD&A: Q3 2026 - Filings
- 2 days ago - Eupraxia Pharmaceuticals initiated with an Outperform at RBC Capital - TheFly